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  GeNeRAl oRTHoPAedicS
Protecting healthcare workers from 
COVID-19: learning from variation in 
practice and policy identified through a 
global cross- sectional survey
Aims
The COVID-19 pandemic presents an unprecedented burden on global healthcare systems, 
and existing infrastructures must adapt and evolve to meet the challenge. With health sys-
tems reliant on the health of their workforce, the importance of protection against disease 
transmission in healthcare workers (HCWs) is clear. This study collated responses from sever-
al countries, provided by clinicians familiar with practice in each location, to identify areas 
of best practice and policy so as to build consensus of those measures that might reduce the 
risk of transmission of COVID-19 to HCWs at work.
Methods
A cross- sectional descriptive survey was designed with ten open and closed questions and 
sent to a representative sample. The sample was selected on a convenience basis of 27 senior 
surgeons, members of an international surgical society, who were all frontline workers in 
the COVID-19 pandemic. This study was reported according to the Standards for Reporting 
Qualitative Research (SRQR) checklist.
Results
Responses were received by all 27 surgeons from 22 countries across six continents. A 
number of the study respondents reported COVID-19- related infection and mortality in 
HCWs in their countries. Differing areas of practice and policy were identified and organ-
ized into themes including the specification of units receiving COVID-19 patients, availa-
bility and usage of personal protective equipment (PPE), other measures to reduce staff 
exposure, and communicating with and supporting HCWs. Areas more specific to surgery 
also identified some variation in practice and policy in relation to visitors to the hospital, 
the outpatient department, and in the operating room for both non- urgent and emergen-
cy care.
conclusion
COVID-19 presents a disproportionate risk to HCWs, potentially resulting in a diminished 
health system capacity, and consequently an impairment to population health. Implementa-
tion of these recommendations at an international level could provide a framework to reduce 
this burden.
Cite this article: Bone Joint Open 2020;1-5:144–151.
Keywords: COVID-19, Coronavirus, healthcare worker, healthcare professional, surgeon, pandemic, personal protective equipment, aerosol 
generating procedure, Policy, SARSCoV-2
introduction
In early 2020, a novel coronavirus rapidly 
spread out of China to the rest of the world.1 
The World Health Organization (WHO) 
declared coronavirus disease 2019 (COVID-
19), secondary to severe acute respiratory 
syndrome coronavirus 2 (SARS- CoV-2),1-3 
a pandemic on 11 March 2020.4 Existing 
health infrastructures around the world were 
unprepared for this unprecedented burden, 
with many hospitals reporting shortages 
in frontline healthcare workers (HCWs), 
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Table i. The ten questions of the cross- sectional descriptive survey.
Number Question
1 How many medical staff were infected in your country?
2 How many of those were surgeons?
3 How many died? Of those that died, how many were surgeons?
4 What measures were taken by the hospital / government 
specifically to protect the medical staff?
5 Were routine outpatient clinics cancelled?
6 How did you manage the trauma patients - both in the 
emergency department and in clinics?
7 Were elective operations cancelled? If not, how were they 
managed?
8 What specific precautions were taken, if any, in the operating 
room?
9 What specific precautions were taken in the outpatient clinic/
ward setting?
10 Were decisions made to manage more patients non- operatively/
conservatively due to Covid-19?
personal protective equipment (PPE), bed space, and 
ventilators in intensive care units (ICUs) relatively early in 
the pandemic.5
With health systems reliant on an adequate workforce, 
it is paramount to protect HCWs by minimizing their risk 
of contracting COVID-19 through work. There is a dual 
benefit to protecting HCWs from developing COVID-
19: to minimize the number of HCWs that are unable to 
work (due to sickness, self- isolation, or quarantine), and 
to minimize transmission of the virus to the vulnerable 
patients for whom they care. HCWs may be exposed to 
many patients positive for COVID-19 who likely display 
more severe features, and consequently longer virus- 
shedding periods.6 This puts HCWs at greater risk than 
those infected through community transmission.
Performing surgical procedures (both elective and 
emergency) present a number of unique challenges 
during the COVID-19 pandemic. The disposable PPE 
equipment (hat, mask, gown, visor, and gloves) used 
during surgical procedures, reduces the supply avail-
able for workers in direct contact with infected patients.7 
Operating rooms (ORs) have positive pressure air filtra-
tion systems that push high volumes of air out of the 
OR. When a patient or HCW with COVID-19 is in the OR, 
they have a greater chance of dispersing the virus.8 Many 
interventions in surgery generate aerosols, including 
the use of power tools.9,10 These aerosols have a poten-
tial to disperse a high viral load to HCWs.11 Additionally, 
some patients undergo non- urgent elective procedures 
requiring routine postoperative inpatient stays, putting 
them at risk of cross- contamination in a hospital with 
other patients carrying COVID-19.
This study aims to identify differences in practice 
and policy in surgery in the context of the COVID-19 
pandemic to inform debate and policy development and 
contribute towards international consensus.
Methods
The study was conducted in accordance with the 2014 
Standards for Reporting Qualitative Research (SRQR), 
endorsed by the EQUATOR network, to ensure trans-
parency in reporting of qualitative research.12 A survey- 
based approach in a non- experimental design was used 
to describe the reality of the current policies and practices 
in relation to the COVID-19 pandemic. A cross- sectional 
descriptive survey was designed and remained open only 
on the dates between 23 March 2020 and 27 March 2020. 
The survey was developed to allow information to be 
collected on attitudes and behaviour. The questionnaire 
was in English and included ten questions (see Table  I) 
that were self- completed. The questions were a combina-
tion of closed questions to allow comparisons and open 
questions to allow collection of qualitative data. Respon-
dents were also asked to send a copy of their government 
or hospital policy. Administration of the questionnaire by 
the senior author and the subsequent responses were 
conducted via email. Peer relationships existed between 
the senior author and all questionnaire respondents and 
were not thought to influence responses. Due to the time 
sensitivity of this data to inform policy and readers glob-
ally, no specific research tool, pretesting, validity or reli-
ability testing was practical. With figures changing daily, 
an iterative approach was incorporated and all respon-
dents were asked on 5 April 2020, prior to manuscript 
submission, to provide updated morbidity and mortality 
data of HCWs, if available.
The representative sample for the survey was selected 
by convenience sampling from English- speaking senior 
clinicians familiar with practice in each location, practicing 
in major trauma or teaching hospitals with geograph-
ical proximity to the epicentre of each country. In South 
Korea two hospitals were identified, one from the ‘fulmi-
nant’ and another one from the ‘non- fulminant’ zone. In 
all, 27 actively involved in the care of frontline COVID-19 
patients were selected to receive the survey from 22 
countries on six continents. Participants were selected 
as they were likely to express opinions that were repre-
sentative of a broader surgical professional population 
within the corresponding country. Where major differ-
ences in practices were identified between urban and 
rural settings within countries, one opinion was sought 
from each region. Consent to participate was assumed in 
a voluntary response to the survey.
data analysis and synthesis. All responses were electron-
ically collated into a database and grouped by country. 
Data were analyzed prospectively at multiple interims. 
No further sampling was performed when sampling sat-
uration was thought to have been reached. To enhance 
trustworthiness and credibility, all responses were ana-
lyzed independently by two physician authors (ZBH, VK), 
with complementary expertise in epidemiology and sur-
gery respectively. Comparisons were made for responses 
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Fig. 1
World map indicating countries represented by survey respondents. Designed using an open source online tool, mapchart.net.
to closed questions. Written responses to open questions 
that included free text were analyzed by grouping quota-
tions from respondents into themes. This allowed a num-
ber of themes to be developed, with multiple countries 
contributing to each theme.
Results
There were a total of 27 respondents from 22 countries 
on six continents (see Figure 1). Combined, the country 
of origin of the respondents represented 57.5% of the 
world’s population and over 6.6 million medically- 
qualified HCWs. Among countries sampled in this study 
at the time of data collection, there was substantial vari-
ation in the numbers of confirmed COVID-19 cases and 
COVID-19- related mortality figures. All 27 respondents 
worked in major trauma centres in large cities.
In this group, 16/22 (73%) countries reported 
confirmed cases of HCWs contracting COVID-19 infec-
tions in their countries (see Table  II), however specific 
morbidity and mortality rates of HCWs varied vastly 
between countries. At the time of data collection, Spain 
had an estimated 19,400 infected HCWs, representing 
14.4% of all cases in the country, at least 75 of these 
had died, 20 of whom were surgeons. Italy had 11,252 
infected HCWs, 52 of whom had died, including one 
surgeon. China reported that 3019 HCWs were infected, 
87.5% of whom were from Hubei province, and 61 HCWs 
died in total. In the USA, in Massachusetts alone, 924 
cases in HCWs had been reported,13 with the total state 
cases of 5,752 at the same time point; therefore, HCWs 
represented around 16% of the infected population. Iran 
had reported 350 infected HCWs, of whom 96 had died. 
Malaysia, South Korea, and Japan and reported 138, 100, 
and 50 to 100 infected HCWs respectively. The UK had 
reported eight HCW deaths but the number infected was 
unknown. All other participant countries were not aware 
of the number or none had been reported.
At the time of data collection, there were respondents 
from six different countries that were aware of COVID-19- 
related mortality in HCWs, but only five of these countries 
(Italy, Spain, Iran, UK, and China) had HCW mortality that 
was directly attributable to frontline work.
Specialist care and isolating coVid-19 pa-
tients. Respondents stated that there were policies in 
place for ‘isolating any confirmed or suspicious cases’ 
with a number of respondents stating that there were re-
gional policies in place for ‘dedicating specific centres to 
deal with such cases’.
Personal protective equipment. In all, 12 out of 22 (55%) 
respondent countries commented on their experience of 
the distribution or use of PPE during the COVID-19 pan-
demic. Comments included the government advice, in 
particular as to the type of face mask. FFP2 (or the equiv-
alent rating N95) masks were specifically mentioned as 
mandatory PPE for treating COVID-19 patients in 8/22 
(36%), as only these masks have protection against aer-
osols. Other respondents described three levels of PPE: 
level 1 = ‘all the medical staff must wear a surgical mask 
in the hospital’; level 2 (for staff working in the emer-
gency department) = ‘N95 mask and isolation gown is 
VOL. 1, NO. 5, MAy 2020
Protecting healthcare workers from coViD-19 147
Table ii. Country profiles of respondents, including population size, number of medically qualified HCWs, and whether they had confirmed COVID-19 
infections in HCWs as of 5 April 2020.
country Population*




Respondents reporting coVid-19 
infections in HcWs
Australia 25,499,884 0.32793735 86,550 yes
Brazil 212,559,417 2.73358784AQ: 453,351 yes
China 1,438,030,215 18.4935674 2,508,408 yes
Egypt 102,334,404 1.31605594 77,083 Unknown
Greece 10,423,054 0.13404409 51,356 Unknown
Hong Kong 14,290
India 1,380,004,385 17.7473351 1,041,395 Unknown
Iran 83,992,949 1.08017846 90,470 yes
Italy 60,461,826 0.77756006 242965 yes
Japan 126,476,461 1.62653117 308,105 yes
Malaysia 32,365,999 0.41623798 46,491 yes
Morocco 36,910,560 0.47468261 25,992 yes
Kenya 53,771,296 0.69151752 8,042 No
Pakistan 220,892,340 2.84075212 184,711 Unknown
Palestine 5,101,414 0.06560595 8,810 No
Singapore 5,850,342 0.07523743 12,967 No
South Africa 59,308,690 0.76273033 51,616 yes
Saudi Arabia 34,813,871 0.44771846 77138 Unknown
South Korea 51,269,185 0.65933951 120,630 yes
Spain 46,754,778 0.60128267 188,595 yes
UK 67,886,011 0.87303765 185,692 yes
USA 331,002,651 4.25680892 835,987 yes
*Source: https://www.worldometers.info/world-population/population-by-country/ ; †World Health Organization (WHO). Global Health Workforce 
Statistics. Retrieved 5 April 2020 (https://apps.who.int/gho/data/node.main.HWF.) ; ‡Figures not reported by WHO.
essential for protection’ ; and for level 3 (staff working 
with confirmed infected COVID-19 patients) ‘protection 
suits, N95 masks, goggle, shoes, sleeves, and work caps’ 
or ‘plastic masks or plastic films can also be used instead 
of goggles’. Some respondents were concerned about 
the availability of PPE in the workplace, reporting that 
PPE was ‘nothing other than giving us a mask’. Others 
stressed the need for education for HCWs in the use of 
PPE ‘HCWs providing care for any patient under investi-
gation, need to have undergone training on the appro-
priate use of PPE’.
limiting HcW exposure, staff testing, self-isolation, and 
support. One respondent noted a policy to reduce staff 
exposure by ‘rotating teams: one team working in hos-
pital, one team in teaching/academic/teleconference’ ac-
tivity. Other respondents reported that with the reduced 
activity, HCWs had reduced exposure as ‘2/3 staff [were 
sent] on extraordinary leave’.
The issue of testing of symptomatic staff was raised 
by a number of respondents with some stating that 
there was access to rapid polymerase chain reaction 
(PCR) testing: ‘PCR performed for medical staff if symp-
toms [were present]’ or that ‘detection kits [were] avail-
able’. Others stated that HCWs at risk or in contact with 
COVID-19 patients had daily occupational health assess-
ments. Others stressed the importance of ‘aggressive 
contact tracing’.
Self- isolation for travelling doctors: some of the respon-
dents specifically mentioned that ‘if a doctor comes from 
abroad, he/she is put in home quarantine for 14 days’ or 
‘quarantine for all staff who have travelled out’.
Some respondents described shielding protocols in 
their countries for vulnerable staff with ‘HCWs involved 
in providing care to confirmed COVID-19 patients should 
not [have a]… high risk condition/immunocompromised 
illness, e.g. uncontrolled diabetes mellitus, chronic lung, 
liver or kidney disease, malignancy, HIV infection, and/or 
not on prolonged steroids or immunosuppressant treat-
ment and non- pregnant’.
One respondent noted that there was a policy in place 
implementing a ‘psychological support team’ for staff 
tested or concerned about developing COVID-19 disease.
communication to staff. Several respondents noted pol-
icy in the hospital to improve communication with staff 
such as ‘regular almost daily updates by SMS or email; on 
symptoms, cases per area and treatment protocols’ with 
others citing regular updates and guidelines by national 
associations.
Visitor and outpatient policies. In most countries, re-
spondents reported that all visitors or those attending 
for outpatient appointments ‘have to answer a question-
naire and their temperatures are checked’, with high- risk 
patients not allowed entry to the hospital and ‘turned 
away to the specific centres dealing with COVID-19’.
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Overall, 20 out of 22 (91%) respondent countries 
reported cancelling or reducing routine outpatient clinics. 
Some respondents stated that ‘appointments are priori-
tised by medical case note review and delayed where 
possible’. Others described a change in practice such that 
‘all of our patients are screened by phone prior to coming 
to the clinic’ and that ‘routine outpatient appointments 
switched to virtual clinics’.
Where outpatients were seen, 8/22 (36%) respondents 
described that arrangements were in place to screen 
all clinic attendants by temperature assessment and/or 
specific questionnaire. Four of the respondents noted 
that all patients attending the outpatient clinic were 
required to wear masks and 10/22 stated that medical 
staff in outpatients were required to wear masks (in some 
cases an FFP2/N95 mask).
A number of respondents reported the measures in 
place for all outpatients and visitors to maintain social 
distancing (ranging from a minimum of 1 m, through 1.5 
m, up to 2 m) and to use hand sanitizer or wash their 
hands.
Some respondents reported that all visitors to hospi-
tals were prevented from entering until further notice.
Trauma and emergency care. While respondents report-
ed that ‘trauma cases are down as people stay at home’ 
due to national ‘lockdowns’, others stated that ‘all cases 
are seen with full PPE precautions. High risk cases were 
also tested before trauma treatment. If positive, referred 
to specialist COVID-19 centres for trauma treatment’. 
Others used a risk- based approach with ‘trauma patients 
screened for travel history and temperature; if positive, 
treated in COVID-19 centres with full precautions’. With 
regional organization in response to COVID-19, some 
hospitals had ‘stopped receiving trauma’, some had mod-
ified practice such as ‘life and limb emergencies treated 
only’ or ‘more nonoperative management’. A number of 
other centres reported ‘no change to routine practice’.
Some respondents noted the importance of ‘mini-
mizing [the] length of stay at hospital’ to reduce infection 
risk to patients and that this was aided by the fact that 
‘elective lists used for trauma to minimize waiting time 
and to empty hospitals’.
Some respondents reported that ‘trauma clinics were 
set up away from the main hospital’ and emergency 
departments.
care in the operating room. Some respondents report-
ed that COVID-19 patients ‘will only be operated by the 
COVID-19 teams set up in each department in full PPE’ 
and that they have specially designated COVID-19 op-
erating rooms with ‘negative pressure’. Others report 
policy that all COVID-19 patients should be operated ‘in 
laminar flow’ ventilated operating rooms.
A number of respondents reported that it was policy 
to ‘PCR pre- op to diagnose asymptomatic patients’ that 
are scheduled to go to the operating room.
Others stated that special precautions were taken 
in the operating room for patients with COVID-19. Of 
particular concern were issues around the anaesthetic. 
Several respondents outlined policy to avoid general 
anaesthesia. With, where possible, ‘all cases done under 
spinal anaesthesia’. Some stated that where intubation 
was needed ‘videoscope aided intubation’ should be 
used and that ‘glasses protection or face shield and N95 
masks’ should be used ‘in intubation’.
General operating room etiquette was to be reinforced 
with respondents stating that ‘masks and gloves worn by 
all’ and that there be ‘minimal staff in theatre’. Additional 
PPE policy was in place according to a number of respon-
dents that included the standard PPE for the operating 
room including eye protection and ‘surgeons wear FFP2 
(mask)’ and ‘triple gloves’.
discussion
The results from this study suggest HCWs could represent 
14% to 16% of the infected population and are therefore 
at a disproportionate risk to the rest of the population. 
Globally, there is substantial variation in measures taken 
to protect HCWs, and some valuable lessons to learn.
The media has recently highlighted HCW concerns 
over contracting COVID-19 at work. Their concerns are 
valid as some countries nearing the peak of their infec-
tion, such as Spain, have reported that 13% to 14% of 
the country’s cases are in HCWs.14,15 Similar reports were 
documented in China. At the start of the outbreak in 
Wuhan, a hospital reported that 40/138 patients (29%) 
were HCWs.16 Another study in Wuhan reported the infec-
tion rate of orthopaedic surgeons was between 1.5% to 
20.7%, and found that the peak onset of infection was 
eight days earlier than that of the public, suggesting 
nosocomial rather than community infection.17 High- 
exposure risks,18 inadequate protection measures,19 and 
health system unpreparedness appear to be important 
factors responsible for the increased risk in HCWs.20 The 
increased risk of infection to HCWs has also been docu-
mented in previous disease outbreaks.21,22
Although this study shows variation in measures taken 
to protect HCWs, it also demonstrates common themes. 
Before the COVID-19 pandemic, in response to previous 
outbreaks, Hong Kong had developed a robust infrastruc-
ture and policy to be implemented immediately should 
another outbreak occur.23,24 In response to the COVID-19 
pandemic, other countries also rapidly instituted simple 
and evidence- based public health measures to minimize 
transmission to HCWs.1,25 The effects of these measures are 
seen in the answers from respondents in this study. A broad 
spectrum of practices and policies are reported in our 
results, with some respondents reporting that their coun-
tries (e.g. Hong Kong and Singapore) implemented and 
adhered to strict regulations early.26 Policies included risk 
stratification e.g. questioning and temperature recordings 
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of all patients, visitors and HCWs entering the hospital. 
Time will tell whether these policies will be successful in 
protecting HCWs, but early impressions suggest they offer 
benefit. Some of the social isolation and lockdown policies 
implemented for COVID-19 resemble the traffic- control 
bundling protocols that were successfully developed 
during the SARS outbreak.27
Respondents in this study highlighted the impor-
tance of communication of COVID-19 guidelines and 
education for HCWs (e.g. in Hong Kong and Malaysia). 
Training schemes like these have also been used in China 
and South Korea to reduce transmission of the infec-
tion.1,17,28 Additionally, strategies have been implemented 
to protect the education and training of residents in the 
USA, while also reducing their exposure through rotating 
teams on 'active duty' or 'working remotely' with phase 
transitions every two weeks, which has been described in 
detail by Schwartz et al.29 Education can also be delivered 
through online streaming (e.g. Singapore).26
PPE has been in critically short supply globally.5,30 The 
respondents in this study have suggested ways to stratify 
risk to HCWs (through levels) to conserve the supply of 
PPE. Initial reports from China have also provided guid-
ance.19 The US Centers for Disease Control and Prevention 
(CDC) and other professional bodies released guidance on 
context- dependent appropriate usage of PPE in response to 
COVID-19.31,32 With limited supplies, advice about re- using 
and repurposing equipment has also been provided.33 
Additionally, methods for dealing with surges in demand 
from previous infectious disease outbreaks have previously 
been documented and have informed policy during the 
COVID-19 outbreak.34 Policies surrounding mask usage 
vary, with some countries introducing mass- masking (e.g. 
China), but due to a thin evidence- base, guidance in other 
countries have been slow.35
The respondents in our study report that several 
countries have adopted surveillance schemes of HCWs 
during the COVID-19 pandemic. Others have empha-
sized the importance of supporting psychological well-
being of HCWs at a time of extreme stress. Advocacy to 
provide social and mental health support have been well 
documented in the literature.27,36,37 Wellbeing advice has 
included shorter working hours, regular rest periods, and 
rotating shifts for those working in high- risk areas.37
The respondents to our study reported that most 
countries affected by the pandemic stopped non- urgent 
outpatient work and surgery. Some reported that they 
were able to introduce telemedicine or ‘virtual’ consul-
tations, which received reimbursement in the USA.38 In 
a new style of practicing medicine, helpful guidance has 
been issued on the appropriate use of video consulta-
tions.39-41 This transition potentially minimizes transmis-
sion risk to HCWs. The positive consequences of these 
practices for elective and non- urgent care have been well 
documented in Singapore.26
Defining non- urgent care has been controversial. The 
American College of Surgeons recently released a triaging 
framework to assist with decision- making, and the Elec-
tive Surgery Acuity Scale (ESAS) intended to be applied 
on a case- by- case basis.42 The Royal College of Surgeons 
have also advised that triage should avoid “blanket poli-
cies” but rather rely on a day- by- day, data- driven assess-
ment of the changing risk–benefit analysis, taking into 
account expert clinical opinion and a site- specific gran-
ular understanding of the logistical issues at play.43 Addi-
tionally, the National Health Service in the UK released 
in- depth guidance for many specialties on approaches to 
urgent and non- urgent care.44 There has been variable 
uptake of this guidance.45
This study highlights novel practice in urgent care 
during the COVID-19 pandemic. Pre- operative testing of all 
patients undergoing urgent procedures is one such area. 
Some countries have adopted this on a universal basis (e.g. 
Hong Kong) or a selective basis for patients with exposure 
history or symptoms (e.g. USA). The COVID-19 causative 
virus, SARS- CoV-2, has been associated with aerosol trans-
mission and nosocomial spread,11 and practical recommen-
dations for critical care and anaesthesiology teams have 
been reported.46 In several settings in our study, protocols 
were followed to minimize the risk of transmission through 
aerosol- generating procedures. These included enhanced 
PPE, minimization of personnel in procedures, and using 
videoscope- aided intubation. Tracheal intubation, non- 
invasive ventilation, and manual ventilation before intu-
bation have all been found to expose HCWs to a higher 
risk.9,46 Several professional bodies have released guidance 
on special PPE precautions during procedures with higher 
risk.32 Surgeons may also be at a substantial risk through 
the use of power tools,10 and other force- generating 
instruments generating tissue spray (e.g. in orthopaedic 
surgery).8 Helpful guidance in minimizing infection risk has 
been published by the European Centre for Disease Preven-
tion and Control.47
The authors acknowledge the non- uniformity and 
selection bias limitations associated with non- random 
convenience sampling in surveys, while recognizing 
the generalizability and internal and external validity of 
the survey approach. The sample size is relatively low 
but does not include response bias as 100% of those 
surveyed responded. There is likely to be variability in the 
practices observed between different surgeons, hospi-
tals, and regions with varying prevalence. However, the 
authors have selected countries to sample from to estab-
lish breadth in points of view.
conclusion
Based on the responses in this study, collating examples 
of best and sometimes novel practice, the authors are 
able to make the following recommendations.
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1. COVID-19 should be treated in specialized, resourced, 
and potentially dedicated centres. A regional approach 
should be taken to treating COVID-19. Designated cen-
tres should have an adequate complement of trained 
staff, recommended equipment and evidence- based pol-
icies for the treatment of COVID-19.
2. Standardized, high- quality, evidence- based PPE should 
be available to all staff. An example policy would be 
based upon three risk levels:
1. Level 1 (low risk, in the ED area where no suspected 
COVID-19 (e.g. unrelated injury and no COVID-19 
symptoms) patients are managed): FFP1 surgical 
masks, eye protection, disposable apron, wrist length 
gloves.
2. Level 2 (medium risk, in the ED area where suspected 
COVID-19 (e.g. respiratory symptoms and/or fever) 
patients are treated and OR: as above, with change-
able clothes (scrubs), impermeable gowns, visors, 
and FFP 2 (N95) masks.
3. Level 3 (high- risk, treating confirmed COVID-19 
patients): as above but isolation suits over all clothes 
and sealed extraction hoods or helmets where 
available.
3. Protecting and supporting staff should be paramount. 
Example policies could include:
1. Rotating teams: minimize number of staff exposed at 
one time.
2. Extraordinary leave: staff who do not need to be at 
work should be at home.
3. Shielding: all at- risk staff with pre- existing conditions 
should self- isolate.
4. Testing: all staff with any symptoms should be rapidly 
tested and if positive they should self- isolate.
5. Support: psychological support should be available 
for all HCWs.
4. Communication: regular or even daily communication 
of the all relevant information and guidance by email 
and/or SMS should take place.
5. Screening: visitors, outpatients and preoperative patients 
should be screened for COVID-19, either by temperature 
and questionnaire assessment or where possible, labora-
tory testing.
6. Reduction in outpatient activity: instituting virtual or 
teleconferencing clinics in place of face- to- face clinics 
where possible.
7. Reduction in operating room activity: non- urgent opera-
tions should be postponed until after the pandemic.
8. Emergency OR policy should be consistent and robust. 
Examples of good policy may include:
1. Only real emergencies should attend the operating 
room at the peak of the pandemic.
2. Patients attending emergency OR should be screened.
3. The OR should have the minimal number of staff.
4. Level 2 PPE needed for all staff in the OR, level three if 
COVID-19- positive patient.
5. Avoid general anaesthesia in COVID-19 patients 
where possible.
COVID-19 presents a disproportionate risk to HCWs, 
potentially resulting in a diminished health system 
capacity, and consequently an impairment to population 
health. Implementation of these recommendations at an 
international level could provide a framework to reduce 
this burden.
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